Postpartum Anxiety, Breastfeeding and Infant Health Among Taiwanese Women
Effects of Postpartum Anxiety on Breastfeeding and Infant Health Among Taiwanese Women: a Longitudinal Study
1 other identifier
observational
315
1 country
1
Brief Summary
This is a prospective, longitudinal and observational study designed to investigate the trajectories of postpartum anxiety and its determinants in the first year after childbirth. This study also examine the associations between postpartum anxiety and infant health outcome, including breastfeeding patterns, excessive crying and body weight growth. Primipara aged 20-49 with term baby will be invited. Demographics, maternal-newborn characteristics, and anxiety symptoms will be collected during the first week postpartum (T1). Questionnaires will be follow-up by mail and telephone reminder in 1 (T2), 3 (T3), 6 (T4) and 12 months (T5) postpartum. The primary outcome is postpartum anxiety using the Spielberger's State-Trait Anxiety Inventory (STAI); the secondary outcomes are infant health outcomes including breastfeeding patterns, excessive crying and body weight growth. A linear mixed model (LMM) is used to determine the trajectories of postpartum anxiety over time and to examine whether specific demographic and maternal characteristics predict the trajectories of postpartum anxiety. The key findings may contribute to promote early identification and secondary preventive interventions for women with postpartum anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedStudy Start
First participant enrolled
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedJuly 25, 2022
July 1, 2022
1.1 years
October 22, 2020
July 22, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Postpartum anxiety
Assessments using the Spielberger's State-Trait Anxiety Inventory (STAI) for self-reported anxiety symptoms
Baseline
Postpartum anxiety
Assessments using the Spielberger's State-Trait Anxiety Inventory (STAI) for self-reported anxiety symptoms
One month from baseline
Postpartum anxiety
Assessments using the Spielberger's State-Trait Anxiety Inventory (STAI) for self-reported anxiety symptoms
Three months from baseline
Postpartum anxiety
Assessments using the Spielberger's State-Trait Anxiety Inventory (STAI) for self-reported anxiety symptoms
Six months from baseline
Postpartum anxiety
Assessments using the Spielberger's State-Trait Anxiety Inventory (STAI) for self-reported anxiety symptoms
Twelve months from baseline
Secondary Outcomes (5)
Infant health outcomes
Baseline
Infant health outcomes
One month from baseline
Infant health outcomes
Three months from baseline
Infant health outcomes
Six months from baseline
Infant health outcomes
Twelve months from baseline
Study Arms (1)
Postpartum Anxiety
Postpartum anxiety will be assessed at 1-3 days (T1), 1(T2), 3 (T3), 6 (T4) and 12 months (T5) postpartum by using the State-Trait Anxiety Inventory (STAI).
Interventions
Postpartum anxiety will be assessed at 1-3 days (T1), 1(T2), 3 (T3), 6 (T4) and 12 months (T5) postpartum by using the State-Trait Anxiety Inventory (STAI) with a score ≥40 serving as a positive screen.
Eligibility Criteria
The subjects will be recruited in 1-3 days postpartum from the birth center or the postpartum ward in the hospitals in northern Taiwan. The well-trained research assistant/registered nurse, responsible for data collection, recognized potential subjects from their medical records, contacted the women and after explaining the aim of study, invited them to complete the baseline questionnaire.
You may qualify if:
- years old
- Primipara
You may not qualify if:
- Preterm birth
- Infants with severe congenital malformations/medical conditions or Fetal/neonatal death
- Current use of antidepressant or antipsychotics
- Thoughts of self-harm or suicide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fu Jen Catholic University
New Taipei City, Xinzhuang Dist, 24205, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuh-Kae Shyu
Fu Jen Catholic University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 22, 2020
First Posted
October 29, 2020
Study Start
November 4, 2020
Primary Completion
November 30, 2021
Study Completion
January 10, 2023
Last Updated
July 25, 2022
Record last verified: 2022-07